Early research (Phase 1)Study completedNCT03424122
What this trial is testing
INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
Who this might be right for
B-cell Lymphoma
Incyte Corporation 50